Atara Bio Announces Proposed Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
ATARA Biotherapeutics (ATRA) Boosts Common Stock Shelf Size to $150M
July 9, 2015 10:07 AM EDTATARA Biotherapeutics (Nasdaq: ATRA) filed an amended registration with the U.S. SEC to sell up to $150 million of its Common Stock. The amount is up from a previously registered amount of $125 million.
... MoreAtara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
July 7, 2015 4:06 PM EDTAtara Biotherapeutics (NASDAQ: ATRA) has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of approximately $125.0 million. In addition, Atara Bio expects to grant the underwriters a 30-day option to purchase up to an... More
